The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?

CDMO industry perspectives & news

Selected articles from industry publications

The factors shaping drug development success are shifting. Operational complexity, global coordination, and execution discipline now play a defining role in whether programs progress or stall.

Across industry publications, our experts share perspectives on how these forces are changing development and what it takes to manage them effectively.

Questions? Contact us 

Industry Perspectives
Choosing a drug development partner in 2026
Choosing a drug development partner in 2026
Learn how to evaluate and choose the right drug development partner in 2026 with a practical framework for assessing CDMO expertise, quality, and risk.
Read the article
Industry Perspectives
Navigating technical challenges in OSD development
Navigating technical challenges in OSD development
Learn a practical framework for overcoming technical challenges in oral solid dose development, from formulation and scale-up to commercial manufacturing.
Read the article
Industry Perspectives
What “one team” really means in drug development
What “one team” really means in drug development
Discover why a true one team approach in drug development improves collaboration, streamlines decision-making, and reduces complexity across programs.
Read the article
Industry Perspectives
How deferred decisions create late-phase pressure
How deferred decisions create late-phase pressure
Learn how deferred development decisions create late-stage pressure in drug development and why earlier CMC, regulatory, and manufacturing alignment matters.
Read the article
Industry Perspectives
The new operational reality of drug development
The new operational reality of drug development
What causes development programs to lose momentum? Often it's not the science. Explore the operational factors that increasingly shape timelines, risk, and execution success.
Read the article
Industry Perspectives
Supporting antibody drug conjugate trials through clinical logistics
Supporting antibody drug conjugate trials through clinical logistics
Clinical logistics for ADC trials must flex with formulation. Liquid and lyophilized products require different shipping, storage, and monitoring to keep supply compliant, timely, and site-ready.
Read the article
Industry Perspectives
Drug development speed: Outcome of early-phase decisions
Drug development speed: Outcome of early-phase decisions
Discover how early drug development decisions shape how quickly complex programs move in later phases.
Read the article
Industry Perspectives
What Drives Speed in Complex Drug Development?
What Drives Speed in Complex Drug Development?
Learn what truly drives speed in complex drug development—why coordination, not effort, determines timelines, risk, and execution success.
Read the article